首页> 美国卫生研究院文献>World Journal of Gastroenterology >Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells
【2h】

Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells

机译:甲胎蛋白通过改变Fas / FasL的表达以及与肿瘤坏死因子相关的凋亡诱导配体及其淋巴细胞和肝癌细胞受体来触发逃避免疫监视的肝癌细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate the mechanism of α-fetoprotein (AFP) in escaping from the host immune surveillance of hepatoc-ellular carcinoma.METHODS: AFP purified from human umbilical blood was administrated into the cultured human lymphoma Jurkat T cell line or hepatoma cell line, Bel7402 in vitro. The expression of tumor necrosis factor related apoptosis-inducing ligand (TRAIL) and its receptor (TRAILR) mRNA were analyzed by Northern blot and Western blot was used to detect the expression of Fas and Fas ligand (FasL) protein.RESULTS: AFP (20 mg/L) could promote the expression of FasL and TRAIL, and inhibit the expression of Fas and TRAILR of Bel7402 cells. For Jurkat cell line, AFP could suppress the expression of FasL and TRAIL, and stimulate the expression of Fas and TRAILR. AFP also could synergize with Bel7402 cells to inhibit the expression of FasL protein and TRAIL mRNA in Jurkat cells. The monoclonal antibody against AFP (anti-AFP) could abolish these functions of AFP.CONCLUSION: AFP is able to promote the expression of FasL and TRAIL in hepatoma cells and enhance the expression of Fas and TRAILR in lymphocytes. These could elicit the escape of hepatocellular carcinoma cells from the host’s lymphocytes immune surveillance.
机译:目的:探讨α-甲胎蛋白(AFP)逃脱宿主对肝细胞癌的免疫监视的机制。方法:将从人脐带血中纯化的AFP给予培养的人淋巴瘤Jurkat T细胞系或肝癌细胞系, Bel7402体外。结果:AFP(20)通过Northern blot和Western blot方法检测肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其受体(TRAILR)mRNA的表达。 mg / L)可促进FasL和TRAIL的表达,并抑制Bel7402细胞Fas和TRAILR的表达。对于Jurkat细胞系,AFP可以抑制FasL和TRAIL的表达,并刺激Fas和TRAILR的表达。 AFP还可以与Bel7402细胞协同作用,以抑制Jurkat细胞中FasL蛋白和TRAIL mRNA的表达。结论:AFP能够促进肝癌细胞FasL和TRAIL的表达,并能促进Fas和TRAILR在淋巴细胞中的表达。这些可能促使肝细胞癌细胞脱离宿主的淋巴细胞免疫监视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号